2168 Circulation December 1, 2015 sufficient evidence for health benefit exists to implement
case finding via family history–based screening, cascade screening, or other strategies …

Familial hypercholesterolaemia is common in individuals who had a myocardial infarction at
a young age. As many as one in 200 people could have heterozygous familial …

Abstract An Expert Panel convened by the National Lipid Association previously developed
a consensus set of recommendations for the patient-centered management of dyslipidemia …

BACKGROUND: Homozygous familial hypercholesterolemia (HoFH) is a rare genetic
disorder characterized by severely elevated low-density lipoprotein cholesterol (LDL-C) …

Background—Cardiovascular disease burden and treatment patterns among patients with
familial hypercholesterolemia (FH) in the United States remain poorly described. In 2013 …

Background: Familial hypercholesterolemia (FH) and other extreme elevations in low-
density lipoprotein cholesterol significantly increase the risk of atherosclerotic …

Familial hypercholesterolemia (FH) is an inherited condition resulting in high levels of low-
density lipoprotein cholesterol (LDL-C) and increased risk of premature cardiovascular …

There is compelling evidence that the elevated plasma lipoprotein (a)[Lp (a)] levels increase
the risk of atherosclerotic cardiovascular disease (ASCVD) in the general population. Like …

ABSTRACT Introduction: Familial Hypercholesterolemia (FH) is an inherited disorder
characterized by a defect in the binding and internalization of low-density lipoprotein (LDL) …

Objectives To determine pediatricians' practices, attitudes, and barriers regarding screening
for and treatment of pediatric dyslipidemias in 9-to 11-year-olds and 17-to 21-year-olds …